1951 Stock Overview
An investment holding company, provides assisted reproductive services (ARS) in China and the United States.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 3/6 |
| Past Performance | 4/6 |
| Financial Health | 3/6 |
| Dividends | 2/6 |
Rewards
Risk Analysis
No risks detected for 1951 from our risk checks.
Jinxin Fertility Group Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$2.84 |
| 52 Week High | HK$4.33 |
| 52 Week Low | HK$2.05 |
| Beta | 1.41 |
| 11 Month Change | 17.84% |
| 3 Month Change | 2.16% |
| 1 Year Change | -24.06% |
| 33 Year Change | -75.52% |
| 5 Year Change | -76.33% |
| Change since IPO | -75.09% |
Recent News & Updates
Recent updates
Shareholder Returns
| 1951 | HK Healthcare | HK Market | |
|---|---|---|---|
| 7D | 22.4% | 7.8% | 9.8% |
| 1Y | -24.1% | -32.8% | 12.9% |
Return vs Industry: 1951 exceeded the Hong Kong Healthcare industry which returned -32.8% over the past year.
Return vs Market: 1951 underperformed the Hong Kong Market which returned 12.9% over the past year.
Price Volatility
| 1951 volatility | |
|---|---|
| 1951 Average Weekly Movement | 7.5% |
| Healthcare Industry Average Movement | 5.8% |
| Market Average Movement | 6.6% |
| 10% most volatile stocks in HK Market | 13.6% |
| 10% least volatile stocks in HK Market | 3.5% |
Stable Share Price: 1951 has not had significant price volatility in the past 3 months.
Volatility Over Time: 1951's weekly volatility (8%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1951 | 3,779 | Yang Dong | www.jxr-fertility.com |
Jinxin Fertility Group Limited, an investment holding company, provides assisted reproductive services (ARS) in China and the United States. The company primarily offers two treatment solutions, including artificial insemination that is performed with either husband’s sperm or a donor sperm; and IVF technology, whereby fertilization is achieved through conventional in vitro fertilization and embryo transfer or IVF with intracytoplasmic sperm injection. It also provides related services, such as nutrition guidance, Chinese medicine treatment, and psychological counseling to support the ARS.
Jinxin Fertility Group Limited Fundamentals Summary
| 1951 fundamental statistics | |
|---|---|
| Market cap | HK$7.79b |
| Earnings (TTM) | HK$344.81m |
| Revenue (TTM) | HK$3.22b |
24.9x
P/E Ratio2.7x
P/S RatioIs 1951 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 1951 income statement (TTM) | |
|---|---|
| Revenue | CN¥2.90b |
| Cost of Revenue | CN¥1.70b |
| Gross Profit | CN¥1.19b |
| Other Expenses | CN¥883.30m |
| Earnings | CN¥310.84m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.11 |
| Gross Margin | 41.19% |
| Net Profit Margin | 10.72% |
| Debt/Equity Ratio | 20.9% |
How did 1951 perform over the long term?
See historical performance and comparison